RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2005;98:63
doi:10.1258/jrsm.98.2.63
© 2005 Royal Society of Medicine

This Article
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaber, T. A-Z K
Right arrow Articles by Mannemela, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
J R Soc Med 2005;98:63
© 2005 The Royal Society of Medicine

Botulinum toxin for muscle spasm after tetanus

Tarek A-Z K Gaber MSc MRCP     Sailaja Mannemela MD  

Leigh Infirmary, Greater Manchester WN7 1HS, UK

Correspondence to: Dr T GaberE-mail: tarek.gaber{at}wwl.nhs.uk

Despite routine immunization, tetanus is still occasionally seen in the UK. After the acute episode, long-term neurological and musculoskeletal sequelae are common.1

CASE HISTORY

An intravenous drug user aged 28 sought advice because of trismus and then quickly deteriorated, developing generalized muscle spasms. Respiratory failure required artificial ventilation. Tetanus was diagnosed and he was treated with antibiotics and tetanus human immunoglobulins, together with diazepam and dantrolene to reduce muscle tone. After three weeks he was weaned off the artificial ventilation and transferred to a general medical ward where he improved slowly. However, he continued to have severe muscular rigidity with restriction of movements in the left elbow and both ankles, especially in dorsiflexion. For this we treated him with botulinum toxin (Dysport), a total of 1000 units injected into the left biceps brachii and brachioradialis and both gastrocnemius muscles. By the next day he had regained a full range of movement in both ankles, and elbow movements improved over the next few days. No side-effects were noted. Dantrolene was slowly withdrawn and within two weeks the patient was independently mobile with full movement in both elbows.

COMMENT

Like the tetanic neurotoxin tetanospasmin, botulinum toxin is the product of a clostridial species (Clostridium botulinum). The toxins are similar in structure and in mechanisms of action; the difference in clinical effects is attributable to their neurospecificities. Tetanus neurotoxin binds to the presynaptic membrane of the neuromuscular junction. It is internalized and transported retro-axonally to the spinal cord. The spastic paralysis induced by tetanus toxin is due to blockade of neurotransmitter release from spinal inhibitory interneurons. In contrast, the seven serotypes of botulinum neurotoxin act at the periphery, inhibiting acetylcholine release at the neuromuscular junction and inducing a flaccid paralysis.2

Benzodiazepines and dantrolene are the drugs customarily used for muscle rigidity in tetanus3 but they act generally and are less useful for localized muscle rigidity of the sort experienced by our patient. The successful use of botulinum toxin to manage trismus in cephalic tetanus has been reported by Andrade et al.4 In our patient, use of this agent in peripheral muscle groups appeared to speed return to mobility and may well have helped prevent long-term joint deformities. More than half the survivors of tetanus have evidence of joint damage, which is thought to be due to repeated traction on the periosteum and violent stress on the joint.5

REFERENCES

  1. Illis LS, Taylor FM. Neurological and electroencephalographic sequelae of tetanus. Lancet1971; i:826 –30

  2. Pellizzari R, Rossetto O, Schiavo G, Montecucco C. Tetanus and botulinum neurotoxins; mechanism of action and therapeutic uses. Phil Trans R Soc B1999; 354:259 –68

  3. Tidyman M, Prichard JG, Deamer RL, Mac N. Adjunctive use of dantrolene in severe tetanus. Anesth Analg1985; 64:538 –40[Free Full Text]

  4. Andrade LA, Brucki SM. Botulinum toxin A for trismus in cephalic tetanus. Arq Neuropsiquiatr1994; 52:410 –13[Medline]

  5. Luisto M, Zitting A, Tallroth K. Hyperostosis and osteoarthritis in patients surviving after tetanus. Skeletal Radiol1994; 23:31 –5[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaber, T. A-Z K
Right arrow Articles by Mannemela, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

MDU Exam Doctor